Filing Details

Accession Number:
0001140361-11-039627
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-08-04 13:53:02
Reporting Period:
2011-08-02
Filing Date:
2011-08-04
Accepted Time:
2011-08-04 13:53:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1301173 H Jeffrey Cooper C/O Biomarin Pharmaceutical Inc.
105 Digital Drive
Novato CA 94949
Svp, Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-08-02 18,036 $17.33 57,912 No 4 M Direct
Common Stock Disposition 2011-08-02 18,036 $30.47 39,876 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Disposition 2011-08-02 18,036 $0.00 18,036 $17.33
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
306,336 2007-12-07 2017-06-06 No 4 M Direct
Footnotes
  1. The price in Column 4 is a weighted average price. The prices actually received ranged from $30.25 to $30.75. the reporting person will provide to the issuer, any security holder of the issuer, or SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  2. Original option grant vested 6/48ths on December 7, 2007 and 1/48th on the 7th of every month thereafter.